Form 4: Senseonics CEO Receives Equity Compensation Grant
Statement of Changes in Beneficial Ownership
Senseonics Holdings, Inc. CEO Timothy T. Goodnow was granted 553,701 restricted stock units and 761,923 stock options.
Summary
- CEO Timothy T. Goodnow received a grant of 553,701 restricted stock units (RSUs).
- CEO Timothy T. Goodnow received a grant of 761,923 employee stock options with an exercise price of $5.54.
- The RSUs vest in eight equal installments starting June 15, 2026, and continuing every six months thereafter.
- The stock options vest in 48 equal monthly installments beginning May 19, 2026.
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as a neutral administrative filing regarding executive compensation, which is a standard corporate governance activity.
Positives
- Equity grants align the interests of the CEO with long-term shareholder value through multi-year vesting schedules.
Negatives
- The issuance of new equity results in potential dilution for existing shareholders.
Risks
- Vesting is contingent upon the reporting person's continuous service with the issuer.
Future Outlook
The filing does not provide forward-looking financial guidance, focusing solely on executive compensation structure.
Industry Context
StockSavvy.ai notes that equity-based compensation for executive leadership is standard practice in the medical technology sector to ensure retention and performance alignment.
Comparison to Industry Standards
- The use of multi-year vesting schedules for executive equity is consistent with standard corporate governance practices in the U.S. biotech and medtech industries.
Stakeholder Impact
- Shareholders may experience minor dilution due to the issuance of new equity awards.
Next Steps
- Vesting of the first RSU installment on June 15, 2026.
- Ongoing monthly vesting of stock options.
Key Dates
| Date | Description |
|---|---|
| 05/19/2026 | Date of transaction and commencement of vesting for options. |
| 06/15/2026 | First vesting date for restricted stock units. |
| 05/18/2036 | Expiration date for the granted employee stock options. |
Keywords
Senseonics, SENS, Form 4, Insider Trading, Equity Compensation, CEO
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.